Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma.
Wersäll PJ, Blomgren H, Pisa P, Lax I, Kälkner KM, Svedman C. Wersäll PJ, et al. Among authors: kalkner km. Acta Oncol. 2006;45(4):493-7. doi: 10.1080/02841860600604611. Acta Oncol. 2006. PMID: 16760190 No abstract available.
Temporary effect of arsenic trioxide treatment of refractory extragonadal germ cell cancer.
Kälkner KM, Ullén A, Wersäll P, Cohn-Cedermark G. Kälkner KM, et al. Acta Oncol. 2007;46(6):862-3. doi: 10.1080/02841860601156173. Acta Oncol. 2007. PMID: 17653913 No abstract available.
Clinical outcome in patients with prostate cancer treated with external beam radiotherapy and high dose-rate iridium 192 brachytherapy boost: a 6-year follow-up.
Kälkner KM, Wahlgren T, Ryberg M, Cohn-Cedermark G, Castellanos E, Zimmerman R, Nilsson J, Lundell M, Fowler J, Levitt S, Hellström M, Nilsson S. Kälkner KM, et al. Acta Oncol. 2007;46(7):909-17. doi: 10.1080/02841860601156140. Acta Oncol. 2007. PMID: 17917823 Clinical Trial.
Additive/synergistic antitumoral effects on prostate cancer cells in vitro following treatment with a combination of docetaxel and zoledronic acid.
Ullén A, Lennartsson L, Harmenberg U, Hjelm-Eriksson M, Kälkner KM, Lennernäs B, Nilsson S. Ullén A, et al. Among authors: kalkner km. Acta Oncol. 2005;44(6):644-50. doi: 10.1080/02841860510029617. Acta Oncol. 2005. PMID: 16165924
Estramustine-binding protein (EMBP) in renal cell carcinoma immunohistochemistry, immunoscintigraphy and in vitro estramustine effects.
Edgren M, Westlin JE, Letocha H, Nordgren H, Kälkner KM, Nilsson S. Edgren M, et al. Among authors: kalkner km. Acta Oncol. 1996;35(4):483-8. doi: 10.3109/02841869609109927. Acta Oncol. 1996. PMID: 8695166
A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma.
Svedman C, Sandström P, Pisa P, Blomgren H, Lax I, Kälkner KM, Nilsson S, Wersäll P. Svedman C, et al. Among authors: kalkner km. Acta Oncol. 2006;45(7):870-5. doi: 10.1080/02841860600954875. Acta Oncol. 2006. PMID: 16982552 Clinical Trial.
Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma.
Wersäll PJ, Blomgren H, Lax I, Kälkner KM, Linder C, Lundell G, Nilsson B, Nilsson S, Näslund I, Pisa P, Svedman C. Wersäll PJ, et al. Among authors: kalkner km. Radiother Oncol. 2005 Oct;77(1):88-95. doi: 10.1016/j.radonc.2005.03.022. Epub 2005 Jun 20. Radiother Oncol. 2005. PMID: 15972239 Clinical Trial.
Comorbidity as a predictor of overall survival in prostate cancer patients treated with external beam radiotherapy combined with HDR brachytherapy boosts.
Hjälm-Eriksson M, Ullén A, Johansson H, Levitt S, Nilsson S, Kälkner KM. Hjälm-Eriksson M, et al. Among authors: kalkner km. Acta Oncol. 2017 Jan;56(1):21-26. doi: 10.1080/0284186X.2016.1253864. Epub 2016 Nov 24. Acta Oncol. 2017. PMID: 27882806
Is the use of a surrogate urethra an option in prostate high-dose-rate brachytherapy?
Nilsson J, Kälkner KM, Berg L, Levitt S, Holmberg C, Nilsson S, Lundell M. Nilsson J, et al. Among authors: kalkner km. Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):36-40. doi: 10.1016/j.ijrobp.2007.09.025. Epub 2007 Nov 5. Int J Radiat Oncol Biol Phys. 2008. PMID: 17980507
Dosimetry of anal radiation in high-dose-rate brachytherapy for prostate cancer.
Kälkner KM, Bengtsson E, Eriksson S, Holmberg C, Nilsson S, Levitt S, Lundell M. Kälkner KM, et al. Brachytherapy. 2007 Jan-Mar;6(1):49-52. doi: 10.1016/j.brachy.2006.08.008. Epub 2006 Dec 8. Brachytherapy. 2007. PMID: 17284386 Clinical Trial.
43 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback